These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 38573476)

  • 1. The Main Mechanisms of Mesenchymal Stem Cell-Based Treatments against COVID-19.
    Li J; He S; Yang H; Zhang L; Xiao J; Liang C; Liu S
    Tissue Eng Regen Med; 2024 Jun; 21(4):545-556. PubMed ID: 38573476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications.
    Chen L; Qu J; Kalyani FS; Zhang Q; Fan L; Fang Y; Li Y; Xiang C
    Cell Mol Life Sci; 2022 Feb; 79(3):142. PubMed ID: 35187617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential roles of mesenchymal stem cells and their exosomes in the treatment of COVID-19.
    Cheng X; Jiang M; Long L; Meng J
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):948-961. PubMed ID: 34719217
    [No Abstract]   [Full Text] [Related]  

  • 4. Research Progress of Mesenchymal Stem Cell Therapy for Severe COVID-19.
    Cai Q; Yin F; Hao L; Jiang W
    Stem Cells Dev; 2021 May; 30(9):459-472. PubMed ID: 33715385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell therapy for acute respiratory distress syndrome: from basic to clinics.
    Qin H; Zhao A
    Protein Cell; 2020 Oct; 11(10):707-722. PubMed ID: 32519302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stromal/stem cells (MSCs) and MSC-derived extracellular vesicles in COVID-19-induced ARDS: Mechanisms of action, research progress, challenges, and opportunities.
    Moradinasab S; Pourbagheri-Sigaroodi A; Zafari P; Ghaffari SH; Bashash D
    Int Immunopharmacol; 2021 Aug; 97():107694. PubMed ID: 33932694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesenchymal stem cell treatment for COVID-19.
    Xu R; Feng Z; Wang FS
    EBioMedicine; 2022 Mar; 77():103920. PubMed ID: 35279630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell immunomodulation and regeneration therapeutics as an ameliorative approach for COVID-19 pandemics.
    Yadav P; Vats R; Bano A; Bhardwaj R
    Life Sci; 2020 Dec; 263():118588. PubMed ID: 33049279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives.
    Karakaş N; Üçüncüoğlu S; Uludağ D; Karaoğlan BS; Shah K; Öztürk G
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The promising approach of MSCs therapy for COVID-19 treatment.
    Samanipour R; Tabatabaee S; Delyanee M; Tavakoli A
    Cell Tissue Bank; 2023 Sep; 24(3):597-612. PubMed ID: 36526819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of Potential Therapeutic Utilization of Mesenchymal Stem Cells in COVID-19 Treatment.
    Fang Y; Lao P; Tang L; Chen J; Chen Y; Sun L; Tan W; Fan X
    Cell Transplant; 2023; 32():9636897231184611. PubMed ID: 37395459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunomodulation of Mesenchymal Stem Cells in Acute Lung Injury: From Preclinical Animal Models to Treatment of Severe COVID-19.
    Li JP; Wu KH; Chao WR; Lee YJ; Yang SF; Chao YH
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of mesenchymal stem cells therapy in COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials.
    Lu W; Yan L; Tang X; Wang X; Du J; Zou Z; Li L; Ye J; Zhou L
    J Transl Med; 2024 Jun; 22(1):550. PubMed ID: 38851730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy.
    Barros I; Silva A; de Almeida LP; Miranda CO
    Cytokine Growth Factor Rev; 2021 Apr; 58():114-133. PubMed ID: 33397585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal Stem Cells Therapy for COVID-19: From Basic Research to Clinical Trial.
    Tao YC; Chen EQ
    Curr Stem Cell Res Ther; 2024; 19(1):55-62. PubMed ID: 36654468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect.
    Can A; Coskun H
    Stem Cells Transl Med; 2020 Nov; 9(11):1287-1302. PubMed ID: 32779878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Menstrual Blood-Derived Mesenchymal Stem Cell Therapy for Severe COVID-19 Patients.
    Heidari F; Heidari R; Sabet MN; Hamidieh AA; Saltanatpour Z
    Curr Stem Cell Res Ther; 2024; 19(5):644-652. PubMed ID: 37073149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal Stem Cells in the Treatment of COVID-19, a Promising Future.
    Beghini DG; Horita SI; Henriques-Pons A
    Cells; 2021 Sep; 10(10):. PubMed ID: 34685567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cell therapy for COVID-19, ARDS and pulmonary fibrosis.
    Li Z; Niu S; Guo B; Gao T; Wang L; Wang Y; Wang L; Tan Y; Wu J; Hao J
    Cell Prolif; 2020 Dec; 53(12):e12939. PubMed ID: 33098357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Consideration for Mesenchymal Stem Cells in Treatment of COVID-19.
    Wu KH; Chao YH; Weng TF; Li JP
    Curr Pharm Des; 2022; 28(36):2991-2994. PubMed ID: 36165526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.